Literature DB >> 34207086

Microglia Morphological Changes in the Motor Cortex of hSOD1G93A Transgenic ALS Mice.

Sara Migliarini1, Silvia Scaricamazza2, Cristiana Valle2, Alberto Ferri2, Massimo Pasqualetti1, Elisabetta Ferraro1.   

Abstract

Amyotrophic lateral sclerosis (ALS) is characterized by the progressive degeneration of spinal motor neurons as well as corticospinal (CSN) large pyramidal neurons within cortex layer V. An intense microglia immune response has been associated with both upper and lower motor neuron degeneration in ALS patients, whereas microgliosis occurrence in the motor cortex of hSOD1G93A mice-the best characterized model of this disease-is not clear and remains under debate. Since the impact of microglia cells in the neuronal environment seems to be crucial for both the initiation and the progression of the disease, here we analyzed the motor cortex of hSOD1G93A mice at the onset of symptoms by the immunolabeling of Iba1/TMEM119 double positive cells and confocal microscopy. By means of Sholl analysis, we were able to identify and quantify the presence of presumably activated Iba1/TMEM119-positive microglia cells with shorter and thicker processes as compared to the normal surveilling and more ramified microglia present in WT cortices. We strongly believe that being able to analyze microglia activation in the motor cortex of hSOD1G93A mice is of great importance for defining the timing and the extent of microglia involvement in CSN degeneration and for the identification of the initiation stages of this disease.

Entities:  

Keywords:  SOD1G93A; amyotrophic lateral sclerosis; metabolic reprogramming; microglia; motor cortex; neuroimmunology

Year:  2021        PMID: 34207086     DOI: 10.3390/brainsci11060807

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  2 in total

1.  Neuroimaging Applications for Diagnosis and Therapy of Pathologies in the Central and Peripheral Nervous System.

Authors:  Silvia Middei
Journal:  Brain Sci       Date:  2022-02-01

2.  Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1G93A mice.

Authors:  Silvia Scaricamazza; Illari Salvatori; Susanna Amadio; Valentina Nesci; Alessio Torcinaro; Giacomo Giacovazzo; Aniello Primiano; Michela Gloriani; Niccolò Candelise; Luisa Pieroni; Jean-Philippe Loeffler; Frederique Renè; Cyril Quessada; Tesfaye W Tefera; Hao Wang; Frederik J Steyn; Shyuan T Ngo; Gabriella Dobrowolny; Elisa Lepore; Andrea Urbani; Antonio Musarò; Cinzia Volonté; Elisabetta Ferraro; Roberto Coccurello; Cristiana Valle; Alberto Ferri
Journal:  Br J Pharmacol       Date:  2022-01-13       Impact factor: 9.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.